Evicenter
MarkdownP&T meetings

Evidence library

Drug and disease research

Review source-traceable evidence for drug–indication records, organized by dossier section.

40 records
DrugIndicationEvidenceActions
4D-150
Neovascular age-related macular degeneration
180 sources
Open
Anaphylmdibutepinephrine · AQST-109
Type I allergic reactions including anaphylaxis
122 sources
Open
Aqneursalevacetylleucine · IB1001
Ataxia-telangiectasia
206 sources
Open
Atebriozzilurgisertib · INCB000928
Fibrodysplasia ossificans progressiva
98 sources
Open
AXPAXLIaxitinib intravitreal implant · OTX-TKI
Neovascular age-related macular degeneration
309 sources
Open
AzetukalnerXEN1101
Focal onset seizures
163 sources
Open
Bezuclastinib
Gastrointestinal stromal tumor
76 sources
Open
Bezuclastinib
Nonadvanced systemic mastocytosis
62 sources
Open
BIM-IOL System
Open-angle glaucoma or ocular hypertension
129 sources
Open
Cytisinicline
Smoking cessation
86 sources
Open
DeramiocelCAP-1002
Duchenne muscular dystrophy
92 sources
Open
DersimelagonMT-7117
Erythropoietic protoporphyria or X-linked protoporphyria
100 sources
Open
Duravyuvorolanib intravitreal insert · EYP-1901
Wet age-related macular degeneration
139 sources
Open
Emcitatetiratricol
MCT8 deficiency
78 sources
Open
Emiltatug ledadotinEmi-Le · XMT-1660
Adenoid cystic carcinoma with solid histology or high-grade transformation
125 sources
Open
Hibsagobepirovirsen · GSK3228836
Chronic hepatitis B virus infection in adults without cirrhosis
190 sources
Open
Hovilpripritelivir · AIC316
Refractory mucocutaneous herpes simplex virus infection in immunocompromised adults
239 sources
Open
Imlifidase
Kidney transplantation in highly sensitized patients
85 sources
Open
Imsidolimab
Generalized pustular psoriasis
85 sources
Open
Ivonescimab
EGFR-mutated non-small-cell lung cancer
79 sources
Open
Juvmotavapadon · CVL-751
Parkinson's disease
218 sources
Open
LB-102
Schizophrenia
345 sources
Open
LirafugratinibLyrfigtu · RLY-4008
Previously treated FGFR2 fusion or rearrangement-positive cholangiocarcinoma
158 sources
Open
Lonvoguran ziclumeranlonvo-z · NTLA-2002
Hereditary angioedema
82 sources
Open
Lytenavabevacizumab-vikg
Neovascular age-related macular degeneration
50 sources
Open
Molgramostim Inhalation Solution
Autoimmune pulmonary alveolar proteinosis
90 sources
Open
QTORIN rapamycin 3.9 percent gel
Microcystic lymphatic malformations
78 sources
Open
Relutrigine
SCN2A- and SCN8A-related developmental and epileptic encephalopathies
72 sources
Open
RP-A501AAV9.LAMP2B
Danon disease
300 sources
Open
Saroglitazar
Primary biliary cholangitis
81 sources
Open
SKY-0515
Huntington's disease
211 sources
Open
SL1009sodium dichloroacetate
Pyruvate dehydrogenase complex deficiency
78 sources
Open
TinlarebantLBS-008
Stargardt disease type 1
66 sources
Open
Tirabrutinib
Primary central nervous system lymphoma
72 sources
Open
TovecimigCTX-009 · ABL001
Second-line advanced biliary tract cancer
90 sources
Open
TovorafenibDAY101 · TAK-580
RAF-altered pediatric low-grade glioma requiring first-line systemic therapy
155 sources
Open
Ulixacaltamide
Essential tremor
78 sources
Open
ZanzalintinibXL092
Metastatic colorectal cancer
65 sources
Open
Zeleciment rostudirsenz-rostudirsen · DYNE-251
Duchenne muscular dystrophy
78 sources
Open
ZipalertinibCLN-081 · TAS6417
EGFR exon 20 insertion-mutated non-small-cell lung cancer
75 sources
Open